Share:
Peer-Reviewed Publication
J Mol Graph Model2025;140109101.November 1, 2025Journal Article

Manipulating high Curie temperature of Sm/Ag doped ZnO monolayers by first-principles GGA+U study.

Hao Yuan1, Yanfang Zhao2, Yuanbin Xiao3, Bing Yang4, Wei Ding5, Jian Lv1
1School of Mechanical Engineering, Jiangsu University of Technology, Changzhou, 213001, China.
2School of Mechanical Engineering, Jiangsu University of Technology, Changzhou, 213001, China; Key Laboratory of Materials Surface Science and Technology of Jiangsu Province Higher Education Institutes (Changzhou University), Changzhou, 213164, China. Electronic address: zhaoyanfang@jsut.edu.cn.
3School of Mechanical Engineering, Jiangsu University of Technology, Changzhou, 213001, China; Key Laboratory of Materials Surface Science and Technology of Jiangsu Province Higher Education Institutes (Changzhou University), Changzhou, 213164, China.
4Key Laboratory of Materials Surface Science and Technology of Jiangsu Province Higher Education Institutes (Changzhou University), Changzhou, 213164, China; Centre for Advanced Laser Manufacturing (CALM), School of Mechanical Engineering, Shandong University of Technology, Zibo, 255000, China.
5School of Electrical Engineering and Automation, Suzhou University of Technology, Changshu, 215500, China.

Abstract

This work studies the electronic structure, and magnetic properties of Sm/Ag doped ZnO monolayer by first-principles GGA + U calculations. The results show Sm-doped ZnO monolayer exhibits stable room temperature ferromagnetism with a high magnetic moment of 5.91 μB per unit. The total magnetic moment of the system is mainly contributed by Sm-4f, and the high Curie temperature results from the stro…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.